Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Sep 28, 2021

Dr. Harvey Kaufman is the Senior Medical Director at Quest Diagnostics and has recently published a study on cancer diagnoses during the pandemic.  Data points to a significant impact of COVID-19 on the rate of cancer screenings and the need to better identify those most at risk for a wide range of cancers.

Harvey...


Sep 28, 2021

Dr. Harvey Kaufman is the Senior Medical Director at Quest Diagnostics and has recently published a study on cancer diagnoses during the pandemic.  Data points to a significant impact of COVID-19 on the rate of cancer screenings and the need to better identify those most at risk for a wide range of cancers.

Harvey...


Aug 16, 2021

Dr. Steve Worland is President and CEO of eFFECTOR Therapeutics a pioneer in the Genomics 3.0 category putting to work the research on selective translation regulator inhibitors (STRIs) and the key ways that cancer cells change their behavior and also change the immune system.

Steve says, "There are two revolutions in...


Aug 16, 2021

Dr. Steve Worland is President and CEO of eFFECTOR Therapeutics a pioneer in the Genomics 3.0 category putting to work the research on selective translation regulator inhibitors (STRIs) and the key ways that cancer cells change their behavior and also change the immune system.

Steve says, "There are two revolutions in...


May 10, 2021

Dr. Marc Hedrick, President and CEO, PLUS Therapeutics describes the challenges of fighting brain cancers like glioblastoma. The PLUS lead investigational asset Rhenium NanoLiposome (RNL) delivers radiation directly to the tumor using a method called Convection Enhanced Delivery.  This approach allows the neurosurgeon...